Of interest, we found that a Rab GTPase inhibitor, dynamin, also blocked the activity of KIAA1429 in CML cells (Fig. S3E, F). This evidence concerns the gene VIRMA and chronic myelogenous leukemia, BCR-ABL1 positive.